OBJECTIVE： To observe the effects and safety of Qijiao shengbai capsule on cardiac function， fenal tunction， peripheral routine blood test and celluar immunity indexes of patients with myocardial infarction complicated with hypertension. METHODS： 58 patients with myocardial infarction complicated with hypertension in our hospital were selected and divided into control group and the observation group， with 29 cases in each group according to the even and odd number of hospitalization order. Control group was given symptomatic treatment as bringing down high blood pressure， regulating blood lipid and preventing myocardial infarction. On this basis， observation group was additionally treated with Qijiao shengbai capsule 2.0 g，po，tid. Treatment course of 2 groups lasted for 6 months. Cardiac function， renal function， peripheral routine blood test， Tcell subset and the occurrence of ADR were observed in 2 groups before and after treatment. RESULTS： Before treatment， there were no statistical significance in above indexes between 2 groups （P＞0.05）. After treatment， LVSd， LVDd， IVSDT and LVPWT of 2 groups were all decreased significantly， with statistical significance （P＜0.05）； there was no statistical significance between 2 groups （P＞0.05）. MAU and UA of observation group and MAU of control group were decreased significantly after treatment； eGFR of observation group was increased significantly， with statistical significance （P＜0.05）. The improvement of above indexes in observation group were significantly better than in control group， with statistical significance （P＜0.05）. The change of peripheral routine blood indexes and T lymphocyte subset in obserration group were greater than in control group， with statistical signifrcance （P＜0.05）. No obvious ADR was found in observation group. CONCLUSIONS： Qijiao shengbai capsule do not influence cardiac function of myocardial infarction patients with hypertension， can protect renal function and strengthen body immunity function with good safety.